RESUMO
The Swiss Cohort Study on Air Pollution and Lung and Heart Disease in Adults (SAPALDIA), a population cohort study, used heated-wire spirometers in 1991 and 2002 and then ultrasonic spirometers in 2010 revealing measurement bias in healthy never smokers. To provide a practical method to control for measurement bias given the replacement of spirometer in long-term population studies, we built spirometer-specific reference equations from healthy never smokers participating in 1991, 2002, and 2010 to derive individualized corrections terms. We compared yearly lung function decline without corrections terms with fixed terms that were obtained from a quasi-experimental study and individualized terms. Compared with baseline reference equations, spirometer-specific reference equations predicted lower lung function. The mean measurement bias increased with age and height. The decline in forced expiratory volume in 1 second during the reference period of 1991-2002 was 31.5 (standard deviation (SD), 28.7) mL/year while, after spirometer replacement, uncorrected, corrected by fixed term, and individualized term, the declines were 47.0 (SD, 30.1), 40.4 (SD, 30.1), and 30.4 (SD, 29.9) mL/year, respectively. In healthy never smokers, ultrasonic spirometers record lower lung function values than heated-wire spirometers. This measurement bias is sizeable enough to be relevant for researchers and clinicians. Future reference equations should account for not only anthropometric variables but also spirometer type. We provide a novel method to address spirometer replacement in cohort studies.
Assuntos
Espirometria/instrumentação , Capacidade Vital , Adulto , Idoso , Viés , Estudos de Coortes , Feminino , Volume Expiratório Forçado , Humanos , Medidas de Volume Pulmonar/instrumentação , Masculino , Fumar/fisiopatologia , Ultrassom , Adulto JovemRESUMO
Primary spontaneous pneumothorax (PSP) affects young healthy people with a significant recurrence rate. Recent advances in treatment have been variably implemented in clinical practice. This statement reviews the latest developments and concepts to improve clinical management and stimulate further research.The European Respiratory Society's Scientific Committee established a multidisciplinary team of pulmonologists and surgeons to produce a comprehensive review of available scientific evidence.Smoking remains the main risk factor of PSP. Routine smoking cessation is advised. More prospective data are required to better define the PSP population and incidence of recurrence. In first episodes of PSP, treatment approach is driven by symptoms rather than PSP size. The role of bullae rupture as the cause of air leakage remains unclear, implying that any treatment of PSP recurrence includes pleurodesis. Talc poudrage pleurodesis by thoracoscopy is safe, provided calibrated talc is available. Video-assisted thoracic surgery is preferred to thoracotomy as a surgical approach.In first episodes of PSP, aspiration is required only in symptomatic patients. After a persistent or recurrent PSP, definitive treatment including pleurodesis is undertaken. Future randomised controlled trials comparing different strategies are required.
Assuntos
Pneumotórax/diagnóstico , Pneumotórax/epidemiologia , Pneumotórax/cirurgia , Comitês Consultivos , Antiperspirantes , Humanos , Pleurodese , Guias de Prática Clínica como Assunto , Recidiva , Fumar/efeitos adversos , Sociedades Médicas , Talco/uso terapêutico , Cirurgia Torácica Vídeoassistida , ToracotomiaRESUMO
Bilirubin is a strong antioxidant. Increased serum levels have been associated with lower respiratory disease and mortality risk. We studied the association of bilirubin with lung function in the Swiss study on Air Pollution and Lung Disease in adults (SAPALDIA) cohort. Associations between natural logarithmised bilirubin and forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), FEV1/FVC and mean forced expiratory flow between 25%-75% of FVC (FEF25-75%) were tested using multiple linear regression in the whole study population (n=4195) and strata of ever-smoking and high body mass index (BMI, defined by the highest distribution quartile). Associations were retested with single nucleotide polymorphism rs6742078, a genetic determinant of bilirubin. High bilirubin levels were significantly associated with higher FEV1/FVC and FEF25-75% overall. Upon stratification, significant associations persisted in ever-smokers, amounting to 1.1% (95% CI 0.1-2.2%) increase in FEV1/FVC, and 116.2 mL·s(-1) (95% CI -15.9-248.4 mL·s(-1)) in FEF25-75% per interquartile range of bilirubin exposure in smokers with high BMI. Associations were positive but nonsignificant in never-smokers with high BMI. Similarly, rs6742078 genotype TT was associated with increased FEV1/FVC and FEF25-75%. Our results suggest a possible protective role of bilirubin on lung tissue, which could be important for prevention and therapy.
Assuntos
Bilirrubina/sangue , Transtornos Respiratórios/genética , Transtornos Respiratórios/fisiopatologia , Adolescente , Adulto , Biomarcadores/sangue , Índice de Massa Corporal , Estudos de Coortes , Feminino , Volume Expiratório Forçado , Genótipo , Humanos , Modelos Lineares , Pulmão/fisiologia , Pulmão/fisiopatologia , Masculino , Pessoa de Meia-Idade , Transtornos Respiratórios/sangue , Testes de Função Respiratória , Fumar/efeitos adversos , Espirometria , Suíça , Capacidade Vital , Adulto JovemRESUMO
Alveolar proteinosis is a rare disease, characterized by accumulation of surfactant in alveoli. Various forms have been identified (congenital, secondary or auto-immune). Treatment is to be reserved for patients that experience moderate to severe symptoms. It requires whole lung lavages, in order to clear the alveoli from the proteinaceous material. Macrophages dysfunction plays a crucial role in the development of the disease and causes immunodeficiency, which in turn can promote opportunistic infections, in patients a priori thought to be immunocompetent.
Assuntos
Lavagem Broncoalveolar/métodos , Macrófagos/patologia , Proteinose Alveolar Pulmonar/terapia , Humanos , Hospedeiro Imunocomprometido , Masculino , Pessoa de Meia-Idade , Infecções Oportunistas/etiologia , Proteinose Alveolar Pulmonar/complicações , Proteinose Alveolar Pulmonar/imunologia , Índice de Gravidade de DoençaRESUMO
BACKGROUND: Children exposed to biomass used in households are at risk to develop diseases or respiratory symptoms. In Madagascar more than 95% of households use it daily. The main objective is to study the impact of chronic exposure to biomass on respiratory health of children under 15 years old in Madagascar. METHODS: Descriptive cross-sectional study conducted with questionnaires among urban and rural population of Antananarivo and Mahajanga provinces between 2016 and 2017. Variables were collected: number of hours spent in kitchen per day, respiratory symptoms and spirometric data. Categorized symptoms score and exposure index expressing chronic exposure to biomass were analyzed with multinomial logistic regression models. RESULTS: Of the 661 children included in the analysis, 27.7% had 1 respiratory symptom and 29.3% had 2 or more respiratory symptoms. Moderate exposure index (aOR=1.57; CI95%=[1.30-1.89]; p<0.001) and high exposure index (aOR=1.76; CI95%=[1.39-2.24]; p<0.001) were significantly associated with 1 respiratory symptom, adjusted with provinces, household members and visitors smoking, perceived discomfort related to air pollution and birthweight. Exposure index was not significantly associated with an increased risk of having 2 or more respiratory symptoms (p = 0.754). CONCLUSION: Respiratory symptoms were associated with exposure to biomass, living in coastal areas, birthweight, tobacco and perceived discomfort related to air pollution. Recommendations and actions must be implemented in order to improve respiratory health related to biomass among children.
Assuntos
Poluição do Ar em Ambientes Fechados , Fumaça , Humanos , Criança , Adolescente , Fumaça/efeitos adversos , Biomassa , Estudos Transversais , Peso ao Nascer , Madagáscar/epidemiologia , Poluição do Ar em Ambientes Fechados/efeitos adversosRESUMO
Primary spontaneous pneumothorax (PSP) is by definition not associated with any underlying lung disease. However, this does not mean that there is no underlying pathological process. It has become increasingly apparent over recent years that PSP is associated with diffuse and often bilateral abnormalities within the pleura and is not simply a disease caused by ruptured blebs/bullae. The pathological process includes emphysema-like changes, pleural porosity and inflammation. In this review, we summarise the recent advances in our understanding of the pathogenesis of PSP and discuss how this relates to management strategies for patients with PSP.
Assuntos
Pneumotórax/etiologia , Humanos , Pneumotórax/patologia , Pneumotórax/terapia , Prevenção SecundáriaRESUMO
BACKGROUND: Bispectral index (BIS) is a valuable tool for assessing the depth of sedation and guiding the administration of sedative drugs. We previously demonstrated the benefits of BIS-guided propofol sedation in patients undergoing flexible bronchoscopy. OBJECTIVE: To examine the feasibility and safety profile of propofol sedation in patients undergoing medical thoracoscopy (MT). METHODS: Patients undergoing MT for diagnostic evaluation or treatment of pleuropulmonary diseases were enrolled over a 2-year period. Nurses and chest physicians were trained by anesthetists to provide analgosedation, to detect and correct cardiopulmonary disturbances. The level of sedation was optimized individually by titrating the propofol infusion according to the BIS and clinical evaluation. Patients' clinical data, procedure time, medications and any adverse events were recorded. RESULTS: Fifty-three patients (60% male) with a median age of 62 years (range 19-84 years) underwent MT. The operative procedure lasted a median time of 28 min (range 9-112 min). The median doses of anesthetic drugs were 145 mg of propofol (range 20-410 mg) and 84 µg of fentanyl (range 0-225 µg). Hemodynamic disturbances occurred in 39 patients (bradycardia n = 4, tachycardia n = 12, hypotension n = 34) and required drug administration in only 4 cases. Hypoxemic events (n = 4) resolved upon gentle patient stimulation (verbal command, chin lift, oral cannula). All patients could be discharged from the recovery unit within 105 min after the procedure. CONCLUSIONS: BIS-guided propofol sedation is a safe method that might replace midazolam sedation in MT and can be managed by well-trained nonanesthesiologist personnel.
Assuntos
Sedação Consciente/métodos , Monitores de Consciência , Hipnóticos e Sedativos/administração & dosagem , Hipnóticos e Sedativos/efeitos adversos , Propofol/administração & dosagem , Propofol/efeitos adversos , Toracoscopia/métodos , Adulto , Idoso , Idoso de 80 Anos ou mais , Estudos de Viabilidade , Feminino , Humanos , Pneumopatias/diagnóstico , Pneumopatias/cirurgia , Masculino , Pessoa de Meia-Idade , Doenças Pleurais/diagnóstico , Doenças Pleurais/cirurgia , Estudos Retrospectivos , Resultado do TratamentoRESUMO
Cystic fibrosis is the most frequent and severe genetic disorder in caucasian children. It is a multisystemic disease progressively involving many organs. Patients' survival was poor most of them dying as children. There has been now however an important improvement of prognosis. The median survival is 38 years today. Such a progress is related to comprehensive care based not only on scientific research but multidisciplinary clinical approach implying physicians and paramedics. Moreover pediatricians stimulated already in the 1960s patient autonomy by supporting national and international patients organisations. This approach has greatly contributed to increase the visibility of this disease and its support in our society. Cystic fibrosis is a paradigm for improving care of chronic diseases in medicine.
Assuntos
Fibrose Cística/terapia , Assistência ao Paciente/normas , Criança , Doença Crônica , Fibrose Cística/epidemiologia , Fibrose Cística/fisiopatologia , Humanos , Prognóstico , SobrevidaRESUMO
Medical thoracoscopy (MT) remains a mini-invasive and very efficient technique to diagnose pleural diseases. In case of pleural effusion of unknown etiology its diagnostic yield is higher than 90%. MT also allows to perform cheap and successful pleurodesis by simple talc insufflation in case of recurring pneumothorax and invalidating malignant pleural effusion with very poor quality of life despite repeated thoracocentes.
Assuntos
Doenças Pleurais/diagnóstico , Derrame Pleural/diagnóstico , Pneumotórax/terapia , Toracoscopia/métodos , Humanos , Doenças Pleurais/etiologia , Doenças Pleurais/patologia , Derrame Pleural/etiologia , Derrame Pleural/patologia , Pleurodese/métodos , Qualidade de Vida , Recidiva , Talco/administração & dosagemRESUMO
A case of hemoptysis may be challenging for clinicians because of the many etiologies involved in this differential diagnosis. Sometimes the cause of this symptom may be very surprising. We present a case of hemoptysis due to ingestion of a blister. This case illustrates the difficulties of identifying rare causes of hemoptysis, especially blister ingestion frequently occurring in old and neurological or cognitive impaired patients.
Assuntos
Embalagem de Medicamentos , Corpos Estranhos/complicações , Hemoptise/etiologia , Idoso , Diagnóstico Diferencial , Hemoptise/diagnóstico , Humanos , ComprimidosRESUMO
At the beginning of the twentieth century, tuberculosis was really a plague. Many people had been mobilised to successfully fight against this infectious disease. Valais, a Swiss alpine canton developped then an original concept of health promotion by involving all the health partners including a specialised hospital under the auspices of the local Health Departement. Such a model named then Ligue pulmonaire contre la tuberculose, celebrates his 60th anniversary. Its present name is Valais Health Promotion, i.e., a proactive health network very unique in Switzerland. It assumes many tasks of public health in clinical as well as in preventive medicine. These two components strongly facilitate the insertion of this organisation into the reality of this population to fulfil many challenging tasks with efficacy.
Assuntos
Promoção da Saúde/história , Promoção da Saúde/tendências , Pneumopatias/prevenção & controle , Educação de Pacientes como Assunto/história , Tuberculose Pulmonar/história , História do Século XX , História do Século XXI , Hospitais de Doenças Crônicas/história , Humanos , Pneumopatias/história , Saúde Pública/história , Fatores de Risco , Escultura/história , Fumar/efeitos adversos , Fumar/história , Sociedades Médicas/história , Suíça , Tuberculose Pulmonar/prevenção & controleRESUMO
BACKGROUND: Air pollution has been associated with impaired health, including reduced lung function in adults. Moving to cleaner areas has been shown to attenuate adverse effects of air pollution on lung function in children but not in adults. METHODS: We conducted a prospective study of 9651 adults (18 to 60 years of age) randomly selected from population registries in 1990 and assessed in 1991, with 8047 participants reassessed in 2002. There was complete information on lung volumes and flows (e.g., forced vital capacity [FVC], forced expiratory volume in 1 second [FEV1], FEV1 as a percentage of FVC, and forced expiratory flow between 25 and 75% of the FVC [FEF25-75]), smoking habits, and spatially resolved concentrations of particulate matter that was less than 10 microm in aerodynamic diameter (PM10) from a validated dispersion model assigned to residential addresses for 4742 participants at both the 1991 and the 2002 assessments and in the intervening years. RESULTS: Overall exposure to individual home outdoor PM10 declined over the 11-year follow-up period (median, -5.3 mug per cubic meter; interquartile range, -7.5 to -4.2). In mixed-model regression analyses, with adjustment for confounders, PM10 concentrations at baseline, and clustering within areas, there were significant negative associations between the decrease in PM10 and the rate of decline in FEV1 (P=0.045), FEV1 as a percentage of FVC (P=0.02), and FEF25-75 (P=0.001). The net effect of a decline of 10 microg of PM10 per cubic meter over an 11-year period was to reduce the annual rate of decline in FEV1 by 9% and of FEF25-75 by 16%. Cumulative exposure in the interval between the two examinations showed similar associations. CONCLUSIONS: Decreasing exposure to airborne particulates appears to attenuate the decline in lung function related to exposure to PM10. The effects are greater in tests reflecting small-airway function.
Assuntos
Poluentes Atmosféricos/efeitos adversos , Exposição Ambiental/análise , Pulmão/fisiologia , Material Particulado/efeitos adversos , Adulto , Envelhecimento/fisiologia , Poluentes Atmosféricos/análise , Exposição Ambiental/efeitos adversos , Monitoramento Ambiental , Feminino , Volume Expiratório Forçado , Humanos , Masculino , Fluxo Máximo Médio Expiratório , Pessoa de Meia-Idade , Material Particulado/análise , Estudos Prospectivos , Análise de Regressão , Fatores de Risco , Fumar/fisiopatologia , Capacidade VitalRESUMO
INTRODUCTION: In lung cancer surgery, large tidal volume and elevated inspiratory pressure are known risk factors of acute lung (ALI). Mechanical ventilation with low tidal volume has been shown to attenuate lung injuries in critically ill patients. In the current study, we assessed the impact of a protective lung ventilation (PLV) protocol in patients undergoing lung cancer resection. METHODS: We performed a secondary analysis of an observational cohort. Demographic, surgical, clinical and outcome data were prospectively collected over a 10-year period. The PLV protocol consisted of small tidal volume, limiting maximal pressure ventilation and adding end-expiratory positive pressure along with recruitment maneuvers. Multivariate analysis with logistic regression was performed and data were compared before and after implementation of the PLV protocol: from 1998 to 2003 (historical group, n = 533) and from 2003 to 2008 (protocol group, n = 558). RESULTS: Baseline patient characteristics were similar in the two cohorts, except for a higher cardiovascular risk profile in the intervention group. During one-lung ventilation, protocol-managed patients had lower tidal volume (5.3 +/- 1.1 vs. 7.1 +/- 1.2 ml/kg in historical controls, P = 0.013) and higher dynamic compliance (45 +/- 8 vs. 32 +/- 7 ml/cmH2O, P = 0.011). After implementing PLV, there was a decreased incidence of acute lung injury (from 3.7% to 0.9%, P < 0.01) and atelectasis (from 8.8 to 5.0, P = 0.018), fewer admissions to the intensive care unit (from 9.4% vs. 2.5%, P < 0.001) and shorter hospital stay (from 14.5 +/- 3.3 vs. 11.8 +/- 4.1, P < 0.01). When adjusted for baseline characteristics, implementation of the open-lung protocol was associated with a reduced risk of acute lung injury (adjusted odds ratio of 0.34 with 95% confidence interval of 0.23 to 0.75; P = 0.002). CONCLUSIONS: Implementing an intraoperative PLV protocol in patients undergoing lung cancer resection was associated with improved postoperative respiratory outcomes as evidence by significantly reduced incidences of acute lung injury and atelectasis along with reduced utilization of intensive care unit resources.
Assuntos
Lesão Pulmonar Aguda/prevenção & controle , Cuidados Intraoperatórios/métodos , Neoplasias Pulmonares/cirurgia , Respiração com Pressão Positiva/métodos , Idoso , Protocolos Clínicos , Estudos de Coortes , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Volume de Ventilação Pulmonar/fisiologia , Resultado do TratamentoRESUMO
PURPOSE OF REVIEW: The present review evaluates the evidence available in the literature tracking perioperative mortality and morbidity as well as the pathogenesis and management of acute lung injury (ALI) in patients undergoing thoracotomy. RECENT FINDINGS: Over the last decade, despite increasing age and comorbid conditions, the operative mortality has remained unchanged for patients undergoing lung resection, whereas procedure-related complications have declined. Better clinical outcomes are achieved in high-volume hospitals and when procedures are performed by a thoracic surgeon. Postthoracotomy ALI has become the leading cause of operative death, its incidence has remained stable (2-5%) and earlier diagnosis can be made by assessing the extravascular lung water volume with the single-indicator dilution technique. The pathogenesis of ALI implicates a multiple-hit sequence of various triggering factors (e.g. oxidative stress and surgical-induced inflammation) in addition to injurious ventilatory settings and genetic predisposition. SUMMARY: Knowledge of the perioperative risk factors of major complications and understanding of the mechanisms of postthoracotomy ALI enable anesthesiologists to implement 'protective' lung strategies including the use of low tidal volume (VT) with recruitment maneuvers, a goal-directed fluid approach and prophylactic treatment with inhaled beta2-adrenergic agonists.
Assuntos
Lesão Pulmonar Aguda/cirurgia , Procedimentos Cirúrgicos Torácicos , Lesão Pulmonar Aguda/diagnóstico , Lesão Pulmonar Aguda/epidemiologia , Lesão Pulmonar Aguda/mortalidade , Humanos , Circulação Pulmonar/fisiologia , Respiração Artificial , Fatores de Risco , Procedimentos Cirúrgicos Torácicos/mortalidade , Resultado do TratamentoRESUMO
We report the observation of a fifty years old man, admitted in the emergency room for bilateral lumbar pain and hyperkaliemic metabolic acidosis, and postrenal kidney failure induced by bilateral hydronephrosis. Radiographic exploration and histologic studies of biopsy confirmed an idiopathic retroperitoneal fibrosis that clinically and biologicaly responded to three seances of hemodialysis, and insertion in each uretere of one double J stent, and long term corticotherapy. The retroperitoneal fibrosis is a little common inflammatory disease, characterized by the development of a fibrous mass around the retroperitoneal structures. His diagnostic means evolved. On the other hand, his treatment was the object of no checked controlled and randomized trial. This article proposes an updating of the knowledge on this subject.
Assuntos
Hidronefrose/complicações , Insuficiência Renal/etiologia , Fibrose Retroperitoneal , Administração Oral , Adulto , Idoso , Anti-Inflamatórios/administração & dosagem , Anti-Inflamatórios/uso terapêutico , Biópsia , Seguimentos , Glucocorticoides/administração & dosagem , Glucocorticoides/uso terapêutico , Humanos , Imunossupressores/uso terapêutico , Injeções Intravenosas , Masculino , Metilprednisolona/administração & dosagem , Metilprednisolona/uso terapêutico , Pessoa de Meia-Idade , Prednisona/administração & dosagem , Prednisona/uso terapêutico , Radiografia Abdominal , Diálise Renal , Fibrose Retroperitoneal/complicações , Fibrose Retroperitoneal/diagnóstico , Fibrose Retroperitoneal/tratamento farmacológico , Fibrose Retroperitoneal/etiologia , Fibrose Retroperitoneal/imunologia , Fibrose Retroperitoneal/patologia , Fatores de Tempo , Tomografia Computadorizada por Raios X , Resultado do TratamentoRESUMO
We report the case of a 60 year female patient suffering from rheumatoid arthritis for the last 25 years, under TNF-blocker and leflunomide, affected by a recurrent pneumothorax with several subpleural nodules, basal bronchiectasis and apical bullous emphysema. The patient was administered several treatments: aspiration, talc pleurodesis, surgical pleurodesis, pleurodesis induced by tetracycline and autologous blood. To allow the pleural inflammatory reaction necessary to the success of the pleurodesis, we had to interrupt the treatment by TNF-blocker and leflunomide. We then witnessed a partial pleurodesis with persistence of a pneumothorax. The medical situation is improving with disappearance of dyspnea.
Assuntos
Antibacterianos/administração & dosagem , Artrite Reumatoide/complicações , Pneumopatias/etiologia , Pleurodese/métodos , Pneumotórax/etiologia , Tetraciclina/administração & dosagem , Antibacterianos/uso terapêutico , Antirreumáticos/administração & dosagem , Antirreumáticos/uso terapêutico , Artrite Reumatoide/tratamento farmacológico , Artrite Reumatoide/fisiopatologia , Bronquiectasia/etiologia , Dispneia/etiologia , Feminino , Humanos , Imunossupressores/administração & dosagem , Imunossupressores/uso terapêutico , Isoxazóis/administração & dosagem , Isoxazóis/uso terapêutico , Leflunomida , Pneumopatias/tratamento farmacológico , Pneumopatias/terapia , Pessoa de Meia-Idade , Doenças Pleurais/etiologia , Pneumotórax/sangue , Pneumotórax/diagnóstico por imagem , Pneumotórax/terapia , Enfisema Pulmonar/etiologia , Radiografia Torácica , Recidiva , Tetraciclina/uso terapêutico , Fatores de Tempo , Resultado do Tratamento , Fator de Necrose Tumoral alfa/antagonistas & inibidoresRESUMO
The pathophysiology and management of primary spontaneous pneumothorax (PSP) are a subject of debate. Despite advances in the understanding of its etiopathogenesis and improvements in its management, implementation in clinical practice is suboptimal. In this manuscript, we review the recent literature with a focus on PSP pathophysiology and management. Blebs and emphysema-like changes (ELC) are thought to contribute to the pathophysiology of PSP but cannot explain all cases. Recent studies emphasize the role of a diffuse porosity of the visceral pleura. Others found a relationship between smoking, occurrence of a PSP and bronchiolitis, which could be the initial pathological process leading to ELC development. Recent or ongoing studies challenge the need to systematically remove air from the pleural cavity of stable patients, introducing conservative management as a valuable therapeutic option. Evidence is growing in favour of needle aspiration instead of chest tube insertion, when air evacuation is needed. In addition, ambulatory management is considered as a successful approach in meta-analyses and is under exploration in a large randomized study. Because of a high recurrence rate of PSP, the benefit of performing a pleurodesis at first occurrence is under evaluation with interesting but not generalizable results. Better identification of 'at risk patients' is needed to improve the investigation strategy. Finally, recent publications confirm the efficacy, security and cost-effectiveness of graded talc poudrage pleurodesis to prevent PSP recurrence. In conclusion, PSP pathophysiology and management are still under investigation. The results of recently published and ongoing studies should be more widely implemented in clinical practice.
Assuntos
Pneumotórax/fisiopatologia , Pneumotórax/terapia , Fumar/efeitos adversos , Vesícula/complicações , Bronquiolite/complicações , Tubos Torácicos/efeitos adversos , Gerenciamento Clínico , Humanos , Masculino , Agulhas/efeitos adversos , Paracentese/métodos , Pleura/anatomia & histologia , Pleurodese/métodos , Pneumotórax/epidemiologia , Guias de Prática Clínica como Assunto , Enfisema Pulmonar/complicações , Recidiva , Fatores de Risco , Talco/administração & dosagem , Talco/uso terapêutico , Cirurgia Torácica Vídeoassistida/métodos , Toracotomia/métodosRESUMO
BACKGROUND: Talc is the most effective chemical pleurodesis agent for patients with malignant pleural effusion. However, concerns have arisen about the safety of intrapleural application of talc, after reports of development of acute respiratory distress syndrome in 1-9% of treated patients. Our aim was to establish whether use of large-particle-size talc is safe in patients with malignant pleural effusion. METHODS: We did a multicentre, open-label, prospective cohort study of 558 patients with malignant pleural effusion who underwent thoracoscopy and talc poudrage with 4 g of calibrated French large-particle talc in 13 European hospitals, and one in South Africa. The primary endpoint was the occurrence of acute respiratory distress syndrome after talc pleurodesis. FINDINGS: No patients developed acute respiratory distress syndrome (frequency 0%, one-sided 95% CI 0-0.54%). 11 (2%) patients died within 30 days. Additionally, seven patients had non-fatal post-thoracoscopy complications (1.2%), including one case of respiratory failure due to unexplained bilateral pneumothorax. INTERPRETATION: Use of large-particle talc for pleurodesis in malignant pleural effusion is safe, and not associated with the development of acute respiratory distress syndrome.